Prostate cancer Prostate cancer
Conditions
Interventions
Sponsors
Tsuji Hiroshi
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) biopsy-proven prostate cancer, 2) age >20 years, 3) T3a-T4N0M0 or PSA >= 20 ng/ml, GS>=8 according to MRI, CT and bone scintigram 4) Performance Status (ECOG), 0-1 5) Expected prognosis > 6 months 6) ability to understand and sign an informed consent form at each institution.
Exclusion criteria
Exclusion criteria: 1) Other therapies except for hormonal therapy 2) Previous radiation therapy to the pelvis 3) Significant excess over the dose-constraints for risk organs 4) Castration-resistant prostate cancer 5) Previous treatment history of TUR-P 6) Active Double cancer 7) Untreatable infection or inflammatory disease in pelvis. 8) a serious medical or psychological condition precluding safe administration of treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse event | — |
Secondary
| Measure | Time frame |
|---|---|
| Biochemical failure free survival rate, Overall survival rate, Non-clinical recurrence rate, Cancer specific survival rate, Evaluation of dose-volume histogram, evaluation of QOL, urethral dose evaluation by using of dosimeter | — |
Contacts
Public ContactHiroshi Tsuji
QST hospital, National Institutes for Quantum Science and Technology
Outcome results
None listed